CD19 CAR-NK Cell Therapy Yields Complete Responses in Waldenstrom NHL | Targeted Oncology
Early results from the ongoing QUILT-106 clinical trial (NCT06334991) show that the treatment combination of CD19 chimeric antigen…
Browsing Category